RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Omics feature selection with the extended SIS R package: identification of a body mass index epigenetic multimarker in the Strong Heart Study
[EN] The statistical analysis of omics data poses a great computational challenge given its ultra-high dimensional nature and frequent between-features correlation. In this work, we extended the Iterative Sure Independence Screening (ISIS) algorithm by pairing ISIS with elastic-net (Enet) and two versions of adaptive Enet (AEnet and MSAEnet) to efficiently improve feature selection and effect estimation in omics research. We subsequently used genome-wide human blood DNA methylation data from American Indians of the Strong Heart Study (N=2,235 participants), measured in 1989-1991, to compare the performance (predictive accuracy, coefficient estimation and computational efficiency) of SIS-paired regularization methods to Bayesian shrinkage and traditional linear regression to identify epigenomic multi-marker of body mass index. ISIS-AEnet outperformed the other methods in prediction. In biological pathway enrichment analysis of genes annotated to BMI-related differentially methylated positions, ISIS-AEnet captured most of the enriched pathways in common for at least two of all the evaluated methods. ISIS-AEnet can favor biological discovery because it identifies the most robust biological pathways while achieving an optimal balance between bias and efficient feature selection. In the extended SIS R package, we also implemented ISIS paired with Cox and logistic regression for time-to-event and binary endpoints, respectively, and bootstrap confidence intervals for the estimated regression coefficients., The Strong Heart Study is funded by grants from the National Heart, Lung, and Blood Institute (NHLBI) (contracts 75N92019D00027, 75N92019D00028, 75N92019D00029, and 75N92019D00030) and previous NHLBI grants (R01HL090863, R01HL109315, R01HL109301, R01HL109284, R01HL109282, and R01HL109319) and cooperative agreements (U01HL41642, U01HL41652, U01HL41654, U01HL65520, and U01HL65521) and by the National Institute of Environmental Health Sciences (grants R01ES021367, R01ES025216, P42ES033719, and P30ES009089). A.D.-R. was supported by a fellowship from the "la Caixa" Foundation (ID100010434; fellowship code LCF/BQ/DR19/11740016). M.T.-P. was supported by Strategic Action for Research in Health Sciences (grant PI15/00071), an initiative from the Instituto de Salud Carlos III and the Spanish Ministry of Science and Innovation and co funded by the European Funds for Regional Development, the Third AstraZeneca Award for Spanish Young Researchers, and the State Agency for Research (grant PID2019-108973RB-C21).
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-108973RB-C21
,
Instituto de Salud Carlos III PI15/00071
,
National Heart 75N92019D00027
,
Lung 75N92019D00028
,
and Blood Institute 75N92019D00029
,
EEUU 75N92019D00030
,
National Heart R01HL109315
,
Lung R01HL109284
,
and Blood Institute U01HL65521
,
EEUU U01HL41642
,
National Heart U01HL41652
,
Lung U01HL41654
,
and Blood Institute U01HL65520
,
EEUU R01HL090863
,
National Heart R01HL109301
,
Lung R01HL109282
,
and Blood Institute R01HL109319
,
EEUU LCF/BQ/DR19/11740016
,
National Heart P30ES009089
,
Lung R01ES021367
,
and Blood Institute R01ES025216
,
EEUU P42ES033719